SCHEMBL16360989

SCHEMBL16360989

C=C(C)c1ccc(S(=O)(=O)C(C)(C)C)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.53
SMN1; SMN2 Q16637 2/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
MEN1 O00255 3/20 0.35
KMT2A Q03164 3/20 0.35
ALOX15 P16050 1/20 0.35
MAPT P10636 4/20 0.35
LMNA P02545 3/20 0.35
HPGD P15428 1/20 0.34
CA12 O43570 1/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
CA9 Q16790 1/20 0.33
CA14 Q9ULX7 1/20 0.33
PTGS2 P35354 1/20 0.33
FFAR4 Q5NUL3 1/20 0.33
MMP1 P03956 1/20 0.33
MMP9 P14780 1/20 0.33
MMP13 P45452 1/20 0.33
NPC1 O15118 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11696351 0.82 ALDH1A1 (0.55) ALDH1A1SMN1; SMN2L3MBTL1MEN1KMT2A
SCHEMBL28824639 0.79 GAA (0.54) ALDH1A1SMN1; SMN2L3MBTL1MEN1KMT2A
SCHEMBL2586791 0.78 CA2 (0.55) ALDH1A1SMN1; SMN2KMT2AALOX15LMNA
SCHEMBL10916595 0.77 ENPP2 (0.54) PTGS2
SCHEMBL565221 0.77 LMNA (0.50) ALDH1A1SMN1; SMN2L3MBTL1MAPTLMNA
SCHEMBL855712 0.76 ALDH1A1 (0.64) ALDH1A1SMN1; SMN2L3MBTL1MEN1KMT2A
SCHEMBL4874561 0.76 CA2 (0.59) ALDH1A1L3MBTL1KMT2AMAPTCA12
Potassium Ion SCHEMBL18916927 0.75 LMNA (0.38) ALDH1A1SMN1; SMN2MAPTLMNAHPGD
SCHEMBL11670825 0.75 LMNA (0.48) ALDH1A1SMN1; SMN2L3MBTL1MAPTLMNA
SCHEMBL11050677 0.75 ALDH1A1 (0.44) ALDH1A1SMN1; SMN2KMT2AMAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013067248-A1 BENZOXAZINES AS MODULATORS OF ION CHANNELS VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-05-10 WO disclosed